| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 08/24/2005 | EP1566442A2 Preparation and use of a human antibody gene bank (human antibody libraries) |
| 08/24/2005 | EP1566437A1 Adsorption of nucleic acids to a solid phase |
| 08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 08/24/2005 | EP1565957A2 Enzyme immobilization for use in biofuel cells and sensors |
| 08/24/2005 | EP1565751A1 Diagnostic and therapeutic use of h-rev107 protein for alzheimer disease |
| 08/24/2005 | EP1565750A2 Methods and kits for assays of rapid screening of diabetes |
| 08/24/2005 | EP1565749A2 Methods of screening for compounds that inhibit the biosynthesis of gpi in malaria parasites |
| 08/24/2005 | EP1565745A2 Isolation and confirmation of analytes from test devices |
| 08/24/2005 | EP1565744A2 Microarrays of cellulose binding chimeric proteins and methods of use thereof |
| 08/24/2005 | EP1565742A2 Predicting animal performance |
| 08/24/2005 | EP1565741A2 Inferring gene regulatory networks from time-ordered gene expression data using differential equations |
| 08/24/2005 | EP1565714A2 Uncaging devices |
| 08/24/2005 | EP1565583A2 Hiv vaccine formulations |
| 08/24/2005 | EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565581A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/24/2005 | EP1565580A2 Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices |
| 08/24/2005 | EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565578A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 08/24/2005 | EP1565577A1 Novel real-time rt-pcr for the sensitive detection of multiple mage gene transcripts |
| 08/24/2005 | EP1565576A2 Method for the detection of microorganisms in pharmaceutical products |
| 08/24/2005 | EP1565575A1 Cancer associated plexinb1 mutations |
| 08/24/2005 | EP1565573A1 Nucleic acid probes and broad-range primers from regions in topoisomerase genes, and methods in which they are used |
| 08/24/2005 | EP1565572A2 Porcine polymorphisms and methods for detecting them |
| 08/24/2005 | EP1565571A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 08/24/2005 | EP1565570A2 Diagnosis of sepsis or sirs using biomarker profiles |
| 08/24/2005 | EP1565569A2 Method for the detection of mutations |
| 08/24/2005 | EP1565568A1 Method for universal detection of micro-organisms and reaction medium therefor |
| 08/24/2005 | EP1565566A2 Protein synthesis monitoring (psm) |
| 08/24/2005 | EP1565565A2 Sol-gel biosensors |
| 08/24/2005 | EP1565560A1 Cot102 insecticidal cotton |
| 08/24/2005 | EP1565559A1 Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same |
| 08/24/2005 | EP1565557A2 Mismatch endonucleases and methods of use |
| 08/24/2005 | EP1565547A2 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565480A2 Detectable labeled nucleoside analogs and methods of use thereof |
| 08/24/2005 | EP1565218A2 Molecules preferentially associated with effector t cells and methods of their use |
| 08/24/2005 | EP1565208A1 The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 08/24/2005 | EP1565204A1 Use of fgf-18 in the diagnosis and treatment of memory disorders |
| 08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
| 08/24/2005 | EP1565140A2 Secretion-testing article |
| 08/24/2005 | EP1530046A9 Method for distinguishing AML subtypes with aberrant and prognostically intermediate karyotypes |
| 08/24/2005 | EP1529115A4 Sir2 activity |
| 08/24/2005 | EP1492440A4 A new method for the diagnosis and prognosis of malignant diseases |
| 08/24/2005 | EP1481371B1 Method for separating a group of cells which are contained in an image sample into individual cells |
| 08/24/2005 | EP1478770A4 Screening method for orthopoxvirus antivirals |
| 08/24/2005 | EP1470243A4 Nucleotide detection method |
| 08/24/2005 | EP1438438A4 Method for attaching nucleic acid molecules to electrically conductive surfaces |
| 08/24/2005 | EP1358356A4 Dna markers for meat tenderness |
| 08/24/2005 | EP1309857B1 A method for detecting a lipoprotein-acute phase protein complex |
| 08/24/2005 | EP1308720B1 Biosensor |
| 08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
| 08/24/2005 | EP1190248B1 Screening methods for compounds which affect melanogenesis |
| 08/24/2005 | EP1007538A4 Probes for the detection of human papillomavirus |
| 08/24/2005 | EP0923598B1 Production and use of normalized dna libraries |
| 08/24/2005 | EP0914470B1 Subtractive amplification |
| 08/24/2005 | EP0832296B1 Enhancement of alkaline phosphatase with sds in chemiluminescent substrates and enzyme inhibition assays |
| 08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 08/24/2005 | EP0684955B1 Nuclear matrix proteins |
| 08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
| 08/24/2005 | CN1659441A Method of assay by oxidation-reduction reaction with formazan |
| 08/24/2005 | CN1659439A Nuclear morphology based identification and quantitation of white blood cell types using optical bio-disc systems |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659437A Method for mapping and eliminating T-cell epitopes |
| 08/24/2005 | CN1659436A Method for isolating ligands |
| 08/24/2005 | CN1659432A Method for detecting ligands and targets in a mixture |
| 08/24/2005 | CN1659425A Metal coated nanocrystalline silicon as an active surface enhanced raman spectroscopy (sers) substrate |
| 08/24/2005 | CN1659287A Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets |
| 08/24/2005 | CN1659286A Method for the simultaneous detection of hybridization and vaccination reactions and diagnostic uses thereof |
| 08/24/2005 | CN1659285A Quality assays for antigen presenting cells |
| 08/24/2005 | CN1659280A La1 - the genome of a lactobacillus strain |
| 08/24/2005 | CN1659278A Fluorescent detection of peroxidase enzymes |
| 08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
| 08/24/2005 | CN1659179A System for tracing animal products |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |
| 08/24/2005 | CN1658901A Methods for treating TWEAK-related conditions |
| 08/24/2005 | CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds |
| 08/24/2005 | CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 08/24/2005 | CN1657940A BRCAAI protein and one breast cancer antigen representation peptide with diagnostic therapeutic value |
| 08/24/2005 | CN1657937A Ryanodine receptor active evaluation method based on protein interaction |
| 08/24/2005 | CN1657933A Determining method and device for residual shelf-date of dairy product in refrigeration chain circulation |
| 08/24/2005 | CN1657916A Fluorescence correlation spectral detection method and device for transgenosis material |
| 08/24/2005 | CN1657635A Process for quickly testing multiple microbiological simultaneously |
| 08/24/2005 | CN1657627A Detection gene of Fasarium graminearum for resisting carbendazim and its detection method |
| 08/24/2005 | CN1657625A Nucleolide specific for O-antigenic of escherichia coli o131 type |
| 08/24/2005 | CN1657623A Rhizoma gastrodiae specific DNA molecule labelled series and its application |
| 08/24/2005 | CN1657620A Characterisation of gene function using double stranded (ds) RNA inhibition |
| 08/24/2005 | CN1657618A Hepatic correlative oncogene inhibitory and use |
| 08/24/2005 | CN1216292C Method for fixing biological macro molecule in common pattern on inorganic silicone material surface |
| 08/24/2005 | CN1216291C Kit for real-time fluorescence quantitative RT-RCR detection of human cancer embryoantigen |
| 08/24/2005 | CN1216153C Method for specificity molecule marker of penicillum IPC strain and its application |
| 08/24/2005 | CN1216074C Mimic peptide of schistosoma japonice ovum antigen and its screening |
| 08/24/2005 | CN1216051C Macrocyclic analogs and method of their use and preparation |
| 08/23/2005 | US6934639 Using the three-dimensional structure of human collagenase-3 (MMP-13), a member of the matrix metalloproteinase (MMP) for drug design of MMP-13 inhibitors |
| 08/23/2005 | US6934636 Methods of genetic cluster analysis and uses thereof |
| 08/23/2005 | US6934408 Method and apparatus for reading reporter labeled beads |
| 08/23/2005 | US6933363 Compositions and methods for therapy and diagnosis of lung cancer |
| 08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
| 08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
| 08/23/2005 | US6933128 Cell-based assay for screening cox-2 inhibitors |
| 08/23/2005 | US6933127 Substrate for PP2C |